Dong-A ST, Sales Increase in Q2, but Operating Profit Decrease Due to R&D Investment
Dong-A ST (Health Korea News / Yu Ji-in) Dong-A ST’s sales increased in the second quarter of this year due to the growth of the prescription drug (ETC) division, but operating profit decreased due to increased R&D costs. Sales increased … Read more